Page last updated: 2024-10-30

vitamin k 3 and Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

vitamin k 3 has been researched along with Precursor T-Cell Lymphoblastic Leukemia-Lymphoma in 1 studies

Vitamin K 3: A synthetic naphthoquinone without the isoprenoid side chain and biological activity, but can be converted to active vitamin K2, menaquinone, after alkylation in vivo.

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma: A leukemia/lymphoma found predominately in children and young adults and characterized LYMPHADENOPATHY and THYMUS GLAND involvement. It most frequently presents as a lymphoma, but a leukemic progression in the bone marrow is common.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nakaoka, E1
Tanaka, S1
Onda, K1
Sugiyama, K1
Hirano, T1

Other Studies

1 other study available for vitamin k 3 and Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

ArticleYear
Effects of Vitamin K3 and K5 on Daunorubicin-resistant Human T Lymphoblastoid Leukemia Cells.
    Anticancer research, 2015, Volume: 35, Issue:11

    Topics: Antibiotics, Antineoplastic; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cel

2015